Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Sep;74(6):863–870. doi: 10.1038/bjc.1996.449

High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.

G R White 1, M Stack 1, M Santibáñez-Koref 1, D S Liscia 1, T Venesio 1, J C Wang 1, C Helms 1, H Donis-Keller 1, D C Betticher 1, H J Altermatt 1, P R Hoban 1, J Heighway 1
PMCID: PMC2074733  PMID: 8826850

Abstract

High levels of loss of distal markers on 17p13.3 in breast cancer suggested the presence within the region of at least one tumour-suppressor gene. Here we describe the derivation of two biallelic polymorphisms from the 17p telomeric yeast artificial chromosome (YAC) TYAC98. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and multiplex PCR analysis demonstrated that the high level of allelic imbalance observed in breast tumours represented loss of constitutional heterozygosity (LOH) and that this LOH extended to the telomere. Lung carcinoma (but not Wilms' tumour)-derived DNA again revealed a high level of loss of subtelomeric 17p sequences. Telomeric microsatellite polymorphisms from other chromosome arms did not show such elevated loss in either tumour type. This suggested that the 17p loss observed did not reflect a general telomeric instability and provided further evidence for the presence of a breast cancer tumour-suppressor gene in the distal region of 17p13.3.

Full text

PDF
863

Images in this article

866Figure 1
on p.866
866Figure 2
on p.866
867Figure 3
on p.867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  2. Betticher D. C., Heighway J., Hasleton P. S., Altermatt H. J., Ryder W. D., Cerny T., Thatcher N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer. 1996 Feb;73(3):294–300. doi: 10.1038/bjc.1996.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Browne D. L., Smith E. A., Dietz-Band J., Riethmann H. C., Phromchotikul T., Litt M. Dinucleotide repeat polymorphism at the human chromosome 11p telomere (D11S2071). Genomics. 1995 Jan 20;25(2):600–601. doi: 10.1016/0888-7543(95)80071-s. [DOI] [PubMed] [Google Scholar]
  4. Call K. M., Glaser T., Ito C. Y., Buckler A. J., Pelletier J., Haber D. A., Rose E. A., Kral A., Yeger H., Lewis W. H. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990 Feb 9;60(3):509–520. doi: 10.1016/0092-8674(90)90601-a. [DOI] [PubMed] [Google Scholar]
  5. Chiba I., Takahashi T., Nau M. M., D'Amico D., Curiel D. T., Mitsudomi T., Buchhagen D. L., Carbone D., Piantadosi S., Koga H. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene. 1990 Oct;5(10):1603–1610. [PubMed] [Google Scholar]
  6. Coles C., Thompson A. M., Elder P. A., Cohen B. B., Mackenzie I. M., Cranston G., Chetty U., Mackay J., Macdonald M., Nakamura Y. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet. 1990 Sep 29;336(8718):761–763. doi: 10.1016/0140-6736(90)93236-i. [DOI] [PubMed] [Google Scholar]
  7. Cornelis R. S., van Vliet M., Vos C. B., Cleton-Jansen A. M., van de Vijver M. J., Peterse J. L., Khan P. M., Børresen A. L., Cornelisse C. J., Devilee P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res. 1994 Aug 1;54(15):4200–4206. [PubMed] [Google Scholar]
  8. Foulkes W. D., Black D. M., Stamp G. W., Solomon E., Trowsdale J. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer. 1993 May 8;54(2):220–225. doi: 10.1002/ijc.2910540210. [DOI] [PubMed] [Google Scholar]
  9. Freije D., Helms C., Watson M. S., Donis-Keller H. Identification of a second pseudoautosomal region near the Xq and Yq telomeres. Science. 1992 Dec 11;258(5089):1784–1787. doi: 10.1126/science.1465614. [DOI] [PubMed] [Google Scholar]
  10. Gerken S. C., Albertsen H., Elsner T., Ballard L., Holik P., Lawrence E., Moore M., Zhao X., White R. A strategy for constructing high-resolution genetic maps of the human genome: a genetic map of chromosome 17p, ordered with meiotic breakpoint-mapping panels. Am J Hum Genet. 1995 Feb;56(2):484–499. [PMC free article] [PubMed] [Google Scholar]
  11. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994 Jun;7(2 Spec No):246–339. doi: 10.1038/ng0694supp-246. [DOI] [PubMed] [Google Scholar]
  12. Hiyama K., Ishioka S., Shirotani Y., Inai K., Hiyama E., Murakami I., Isobe T., Inamizu T., Yamakido M. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene. 1995 Mar 2;10(5):937–944. [PubMed] [Google Scholar]
  13. Hultman T., Ståhl S., Hornes E., Uhlén M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res. 1989 Jul 11;17(13):4937–4946. doi: 10.1093/nar/17.13.4937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Meltzer P. S., Guan X. Y., Trent J. M. Telomere capture stabilizes chromosome breakage. Nat Genet. 1993 Jul;4(3):252–255. doi: 10.1038/ng0793-252. [DOI] [PubMed] [Google Scholar]
  15. Merlo G. R., Venesio T., Bernardi A., Cropp C. S., Diella F., Cappa A. P., Callahan R., Liscia D. S. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas. Cancer Genet Cytogenet. 1994 Sep;76(2):106–111. doi: 10.1016/0165-4608(94)90458-8. [DOI] [PubMed] [Google Scholar]
  16. Mitsudomi T., Steinberg S. M., Nau M. M., Carbone D., D'Amico D., Bodner S., Oie H. K., Linnoila R. I., Mulshine J. L., Minna J. D. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. 1992 Jan;7(1):171–180. [PubMed] [Google Scholar]
  17. Orphanos V., McGown G., Boyle J. M., Santibanez-Koref M. Thirteen dinucleotide repeat polymorphisms on chromosome 6. Hum Mol Genet. 1993 Dec;2(12):2196–2196. doi: 10.1093/hmg/2.12.2196. [DOI] [PubMed] [Google Scholar]
  18. Pandit S. D., Wang J. C., Veile R. A., Mishra S. K., Warlick C. A., Donis-Keller H. Index, comprehensive microsatellite, and unified linkage maps of human chromosome 14 with cytogenetic tie points and a telomere microsatellite marker. Genomics. 1995 Oct 10;29(3):653–664. doi: 10.1006/geno.1995.9953. [DOI] [PubMed] [Google Scholar]
  19. Prosser J., Thompson A. M., Cranston G., Evans H. J. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene. 1990 Oct;5(10):1573–1579. [PubMed] [Google Scholar]
  20. Riley J., Butler R., Ogilvie D., Finniear R., Jenner D., Powell S., Anand R., Smith J. C., Markham A. F. A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res. 1990 May 25;18(10):2887–2890. doi: 10.1093/nar/18.10.2887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shen Y., Kozman H. M., Thompson A., Phillips H. A., Holman K., Nancarrow J., Lane S., Chen L. Z., Apostolou S., Doggett N. A. A PCR-based genetic linkage map of human chromosome 16. Genomics. 1994 Jul 1;22(1):68–76. doi: 10.1006/geno.1994.1346. [DOI] [PubMed] [Google Scholar]
  22. Stack M., Crichton D., Santibanez-Koref M. Two dinucleotide repeat polymorphisms at 17p13. Hum Mol Genet. 1994 Aug;3(8):1443–1443. doi: 10.1093/hmg/3.8.1443. [DOI] [PubMed] [Google Scholar]
  23. Stack M., Jones D., White G., Liscia D. S., Venesio T., Casey G., Crichton D., Varley J., Mitchell E., Heighway J. Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum Mol Genet. 1995 Nov;4(11):2047–2055. doi: 10.1093/hmg/4.11.2047. [DOI] [PubMed] [Google Scholar]
  24. Weinberg R. A. The retinoblastoma gene and cell growth control. Trends Biochem Sci. 1990 May;15(5):199–202. doi: 10.1016/0968-0004(90)90162-5. [DOI] [PubMed] [Google Scholar]
  25. Williamson M. P., Elder P. A., Shaw M. E., Devlin J., Knowles M. A. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet. 1995 Sep;4(9):1569–1577. doi: 10.1093/hmg/4.9.1569. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES